glp 1 pharmacokinetics GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes GLP-1 RAs pharmacokinetics parameters. |

The difference between elevated or unchanged GLP-1 levels in obese patients may be related to differences in metabolic status and detection methods, but the significant correlation between GLP-1 and lipid metabolism suggests that it can control weight and regulate lipid metabolism in HF diet groups, and GLP-1 has the potential to treat obesity caused by HF diet [102]

And I was like, yeah, I really should

Most of the prescriptions for GLP-1s are being written by private sources

Using them in tandem yields better outcomes in many cases

By the end of 2025, WEGOVY was available in 52 countries worldwide, nearly doubling its global footprint, with additional launches planned for 2026, subject to regulatory approvals